| RS138643506 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiovascular phenotype |
| RS138644399 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1386446278 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1386447227 |
WFS1
|
Health Risk |
Likely pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS138644808 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21 |
| RS138645044 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS138646392 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS138646436 |
STS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138646715 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS138646765 |
PTH1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal chondrodysplasia, Jansen type |
| RS138647604 |
STX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism type 1B, Pseudohypoparathyroidism type 1B |
| RS1386476396 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS138648117 |
COL9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL9A3-related disorder |
| RS1386485242 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1386490624 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS1386495377 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS138649664 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS138650597 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1386511892 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group C |
| RS138652066 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS138652506 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138652649 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Immunodeficiency 35 |
| RS1386536852 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS138654170 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal myopathy with anterior tibial onset, Miyoshi muscular dystrophy 1 |
| RS1386542234 |
HYAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS138654444 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia |
| RS1386551513 |
CTSC
|
Health Risk |
Conflicting classifications of pathogenicity |
Periodontitis, aggressive 1 |
| RS138655269 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Van Maldergem syndrome 2, FAT4-related disorder |
| RS138655335 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138655912 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138656216 |
AGK
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 38, Sengers syndrome |
| RS138656755 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
USH2A-related disorder, USH2A-related disorder |
| RS138656762 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Focal segmental glomerulosclerosis |
| RS138656911 |
REEP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS138657343 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Amyloidosis |
| RS1386577803 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS138657991 |
CELSR3
|
Health Risk |
Likely risk allele |
Tourette syndrome, Tourette syndrome |
| RS1386580787 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138658585 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Inborn genetic diseases |
| RS1386586416 |
RNASEH2A
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 4, RNASEH2A-related disorder |
| RS138659167 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS138660534 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138661164 |
TACR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 11 with or without anosmia, Hypogonadotropic hypogonadism 11 with or without anosmia |
| RS1386612395 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS138661581 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS1386626162 |
BCS1L
|
Health Risk |
Pathogenic |
— |
| RS138662754 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1386632671 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS138664031 |
KLHL24
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cardiomyopathy |
| RS1386641968 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1386646132 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS138664823 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS138665095 |
CRAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 8, Neurodegeneration with brain iron accumulation |
| RS1386658293 |
LEMD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dermatofibrosis lenticularis disseminata, Dermatofibrosis lenticularis disseminata |
| RS138667242 |
NHLRC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lafora disease, Lafora disease |
| RS138667578 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138667752 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138667763 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Palmoplantar keratoderma-esophageal carcinoma syndrome |
| RS1386691031 |
LIG4
|
Health Risk |
Pathogenic |
DNA ligase IV deficiency, DNA ligase IV deficiency |
| RS1386696811 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS138670560 |
DCDC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 66, Isolated neonatal sclerosing cholangitis |
| RS1386707595 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS138670775 |
GFM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138671220 |
PITPNM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 5, PITPNM3-related disorder |
| RS138671319 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS138671830 |
UMPS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary orotic aciduria, type 1 |
| RS138671904 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS1386720978 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS138672830 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Inborn genetic diseases |
| RS138673546 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCC2-related disorder, ABCC2-related disorder |
| RS138673993 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS138674014 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS138674440 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A2-related disorder |
| RS138675304 |
CPAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 6, primary |
| RS138675420 |
MLYCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of malonyl-CoA decarboxylase, MLYCD-related disorder |
| RS138677674 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1386789664 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1386803894 |
HPD
|
Health Risk |
Pathogenic |
Hawkinsinuria, Tyrosinemia type III |
| RS138680796 |
ACSF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined malonic and methylmalonic acidemia, Methylmalonic acidemia |
| RS138680809 |
MARVELD2
|
Health Risk |
Conflicting classifications of pathogenicity |
MARVELD2-related disorder, MARVELD2-related disorder |
| RS1386810597 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS138681343 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1386813633 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome |
| RS138681366 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS138681649 |
HAVCR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138682103 |
ITGB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 1, ITGB2-related disorder |
| RS138682163 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 2, Cone-rod dystrophy 3 |
| RS138682290 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS138682654 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, WFS1-related disorder |
| RS138682701 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
UMOD-related disorder, Inborn genetic diseases |
| RS138682847 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS138683303 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1386837360 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
LZTR1-related schwannomatosis, Cardiovascular phenotype |
| RS1386859726 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS138686233 |
ASTN1
|
Health Risk |
Likely pathogenic |
Abnormal brain morphology, Abnormal brain morphology |
| RS138686378 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS138687036 |
G6PD
|
Health Risk |
Pathogenic/Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS138687424 |
GUCY1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya disease with early-onset achalasia, Moyamoya disease with early-onset achalasia |
| RS138687537 |
ANLN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1386875637 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
EHMT1-related disorder, Kleefstra syndrome 1 |